BioBoston supports IND strategy and submission execution so your package is complete, consistent, and aligned to FDA expectations. We help you reduce rework, anticipate questions, and keep timelines moving from preclinical to first in human.
Preclinical, CMC, and clinical alignment in one plan
Our IND Application support can include:
Pre IND meeting preparation, strategy, and briefing materials
IND submission preparation and content coordination
Review and organization of pharmacology and toxicology data
CMC support for Chemistry, Manufacturing, and Controls content
Regulatory submission management and eCTD formatting support
Response planning and support for FDA inquiries and follow up questions
IND timelines slip when sections are built in silos and the narrative is not consistent.
We help you connect the evidence across nonclinical, CMC, and clinical plans so the submission is easier to review, easier to defend, and easier to update as your program evolves.
We define the submission approach, identify gaps, and align on deliverables and responsibilities.
We support drafting, assembly, and submission readiness, then help manage FDA questions through review.
We confirm your product, indication, development stage, and target timeline.
Yes. We can support meeting strategy and briefing materials, then carry that alignment into the submission.
Yes. We can support CMC strategy and documentation coordination aligned to your program stage.
Yes. We help draft and coordinate responses to keep progress moving.